Manuel B. Garcia

Manuel B. Garcia serves as the Senior Director for Educational Technology and Digital Learning at FEU Institute of Technology, Manila, Philippines. Read More

Contact Info

1607, FEU Tech Building,
P. Paredes St, Sampaloc,
Manila, Philippines
mbgarcia@feutech.edu.ph

Follow Me

Can Case Reports Matter When Higher-Level Evidence Is Unavailable?

Case reports can matter when stronger evidence is unavailable, particularly for rare conditions, unusual presentations, emerging phenomena, and signals of unexpected harm. Their value depends on the question being asked, and they usually cannot establish frequency, comparative effectiveness, or causation by themselves.

828
Can Case Reports Matter? Guide 828 of 899
01 · The Question

If case reports are all you have, should you use them?

You search for trials, cohort studies, or other comparative research and find almost nothing. What you do find are individual case reports and perhaps a few small case series.

It is tempting to dismiss them immediately because they sit low in conventional evidence hierarchies. The opposite temptation is equally problematic: if case reports are the only evidence available, perhaps they should simply be treated as the best evidence and used to answer the question.

Neither response is particularly useful.

A case report can contain important evidence. It can document something that has rarely or never been observed, draw attention to an unexpected adverse event, describe an unusual presentation, or show that a particular event occurred under specific circumstances. What it usually cannot tell you is how often that event occurs, whether an intervention generally works, or whether the observed exposure caused the outcome.

The relevant question is therefore not whether case reports are “good” or “bad” evidence. It is what kind of claim the design can reasonably support.

02 · The Short Answer

Case reports can be valuable, but only for questions they can answer

In Brief

Case reports can matter when higher-level evidence is unavailable, especially for identifying rare, novel, unexpected, or poorly documented phenomena and generating signals or hypotheses that warrant further investigation.

They generally cannot estimate incidence or risk without an appropriate denominator, establish comparative effectiveness, or demonstrate causation on their own. Their evidentiary role should therefore remain narrower than that of well-designed comparative studies.

03 · What You Need to Know

A case report can answer “Did this happen?” better than “How often does this happen?”

Case reports describe individual patients, participants, events, or observations in detail. Case series describe multiple cases, usually without a comparison group. Their strength lies in observation rather than comparison.

That distinction becomes particularly important when the literature is sparse.

Case reports can reveal phenomena larger studies were not designed to detect

Some research questions concern events that are rare, unexpected, newly emerging, or difficult to capture prospectively. A large trial may contain no examples simply because the event is extremely uncommon. A case report, by contrast, may exist precisely because something unusual occurred.

Cochrane guidance on adverse effects recognizes that spontaneous case reports and case series may help signal rare and previously unknown events. Such reports can therefore alert researchers to potential harms or phenomena that deserve more systematic investigation.

The same basic logic extends beyond adverse effects. Case reports may document rare diseases, unusual clinical presentations, unexpected intervention responses, novel complications, uncommon combinations of circumstances, or emerging phenomena for which larger studies have not yet accumulated.

The value is often informational rather than estimative: the report tells you that something has been observed and describes the circumstances in which it occurred.

Case reports are particularly useful for signal generation

A signal is not the same as a conclusion.

Suppose several case reports describe the same unexpected adverse event after exposure to a new intervention. The pattern may justify further investigation. It might influence which adverse outcomes researchers monitor in subsequent studies or which hypotheses deserve testing.

But the reports alone do not tell you the probability of the event among everyone exposed. They also do not necessarily establish that the intervention caused it.

Signal An observation or pattern suggesting that a phenomenon may warrant further investigation.
Established effect A conclusion supported by evidence capable of evaluating the relationship with appropriate comparison, measurement, and control of alternative explanations.

This distinction prevents an important inferential leap: moving from “this occurred after the intervention” to “the intervention causes this outcome.”

The missing denominator is a major limitation

Imagine that you find twelve published case reports describing a particular complication after an intervention. Twelve may sound alarming.

But twelve out of what?

If twelve cases occurred among 200 exposed people, the situation looks very different from twelve among twenty million. Published case reports typically do not provide the denominator needed to estimate incidence, prevalence, risk, or event rates. Cochrane explicitly notes this limitation when discussing spontaneous reports.

Why the Denominator Matters
Risk = Number experiencing the event ÷ Number at risk
The numerator is the number of people who experience the event. The denominator is the total number of relevant people exposed or at risk during the defined period.
If a report describes 5 cases but provides no reliable information about how many people were exposed, those 5 cases cannot by themselves establish whether the event occurs in 1 in 20, 1 in 20,000, or 1 in 2,000,000 exposed people.

The existence of cases may still matter. Their frequency remains unknown from those reports alone.

Case reports usually cannot determine comparative effectiveness

Suppose a patient receives an intervention and improves dramatically. That observation may be clinically interesting. It does not establish that the intervention caused the improvement.

Without an appropriate comparison, alternative explanations remain. The condition may have improved naturally. Another treatment may have contributed. Regression toward the mean may matter. The patient's characteristics may be unusual. The outcome may have been measured selectively. Publication itself may be influenced by how remarkable the outcome appeared.

This is why a collection of successful case reports should not be interpreted as though it were a trial without a control group conveniently attached.

Publication processes can make case reports unusually selective

Routine, expected, and uneventful cases are unlikely to inspire a case report. Dramatic outcomes, unusual presentations, unexpected harms, novel responses, and striking coincidences are much more likely to be written up and published.

This selectivity is part of what makes case reports useful for detecting unusual observations. It is also why counting published cases cannot reliably describe how typical those observations are.

There may also be duplicate reporting, incomplete clinical histories, variable diagnostic certainty, inconsistent follow-up, and selective presentation of details. The existence of a publication does not eliminate these limitations.

Case series add cases, but they do not automatically solve the design problem

A case series can reveal whether similar observations occurred in multiple individuals and may provide richer information about patterns across cases. Yet simply increasing the number of cases does not create a comparison group or a reliable denominator.

A series of fifty carefully described cases can be considerably more informative than one isolated report for some descriptive questions. It still does not automatically establish comparative effectiveness or quantify risk.

The evidentiary value depends on the claim

Question What case reports may contribute Major limitation
Can this phenomenon occur? Potentially important direct observation Verification and alternative explanations still matter
What can an unusual presentation look like? Detailed descriptive information May not represent typical presentations
Could this be an unexpected harm? Signal generation, especially for rare events Usually cannot estimate risk or prove causality
How common is the event? Usually little direct help without a denominator Cannot reliably estimate frequency from published cases alone
Does the intervention work better than an alternative? May generate a hypothesis No appropriate comparison for estimating comparative effect
What happens in a rare condition with little other research? May provide valuable descriptive evidence Generalization beyond reported cases remains uncertain

Do not force case reports into a question they were not designed to answer

If higher-level direct evidence is genuinely scarce, case reports may become relatively more important because they contain information unavailable elsewhere. Their methodological limitations do not disappear as the literature becomes smaller.

This principle is easy to overlook. “Best available evidence” is a comparative description. It does not transform the capabilities of a study design.

Case reports can therefore be the best available evidence and still leave the main question substantially unresolved.

Watch Out

Do not convert absence of stronger evidence into permission to make stronger claims from case reports. Scarcity changes how valuable limited evidence may be, not what that evidence can logically establish.

04 · A Practical Example

What can six unusual case reports actually tell you?

Hypothetical Example

An unexpected neurological event after a new intervention

Suppose six published case reports describe a similar neurological event occurring shortly after patients received a relatively new intervention. No randomized trial was designed to investigate this particular event, and large observational safety studies are not yet available.

Observation The reports establish that clinicians have observed and documented a similar event after exposure in several individuals.
Signal The temporal relationship and recurring pattern may justify treating the event as a potential safety signal worthy of targeted investigation.
What remains unknown The reports do not provide a reliable denominator, so you cannot calculate how frequently the event occurs among exposed people.
Causal uncertainty You examine alternative explanations, underlying conditions, concurrent treatments, diagnostic certainty, timing, and whether a biologically plausible mechanism exists. The reports may strengthen or weaken suspicion, but they do not by themselves establish causality.
Appropriate conclusion You report that a potential rare adverse event has been described and warrants further investigation rather than concluding that the intervention has been shown to cause the event at a particular rate.

The six reports matter. The mistake would be asking them to provide information they do not contain.

05 · What Researchers Often Get Wrong

Case reports are often either dismissed too quickly or trusted too much

Misconception

“Case reports are at the bottom of the hierarchy, so they are useless”

Evidence hierarchies are question-dependent. Case reports are poorly suited to estimating comparative treatment effects, but they may be highly informative for detecting rare or unexpected events, describing novel phenomena, and generating hypotheses.

Misconception

“If it happened after the intervention, the intervention caused it”

Temporal sequence is relevant but insufficient for causation. Underlying disease, other exposures, concurrent treatments, chance, measurement problems, and other explanations may account for the observation.

Misconception

“Ten published cases mean the event is common”

Not without knowing the relevant denominator and how cases were ascertained. Published case counts alone cannot establish the rate of an event in the exposed population.

Misconception

“Several case reports showing improvement prove effectiveness”

A series of positive observations remains vulnerable to natural recovery, selection, co-interventions, regression toward the mean, reporting bias, and other explanations. Repetition can strengthen a signal without turning uncontrolled observations into comparative evidence.

Misconception

“Case series solve the weaknesses of case reports”

Case series can provide richer descriptive information and recurring patterns, but they usually retain major limitations such as absence of a comparator and, in many forms, lack of a suitable denominator.

06 · What This Means for You

Match the case evidence to the narrowest defensible claim

If case reports are among the strongest evidence available, start by identifying the specific information you need from them. Do not begin with their position in an evidence hierarchy.

A simple decision framework

If your question concerns a rare, novel, or unexpected phenomenon
Case reports may provide important descriptive evidence and generate a signal for further investigation.
If you need to characterize an unusual presentation or clinical course
Detailed case descriptions may be useful, while recognizing that reported cases may not represent typical cases.
If you need to estimate incidence, prevalence, or risk
Do not derive the estimate from case reports without an appropriate denominator and ascertainment framework.
If you need to determine comparative effectiveness
Treat case reports as hypothesis-generating or supporting observations rather than substitutes for an appropriate comparative design.
If case reports are all that exist
Use them for the claims they can support and make the remaining evidence gap explicit.

Depending on the broader question, other forms of evidence may also deserve attention. A sparse literature may contain small qualitative studies that answer different but important questions, or relevant information may exist outside conventional journals and require a more extensive search of grey literature.

None of these sources needs to impersonate a randomized trial to be useful. Their value comes from asking them the questions they are equipped to answer.

07 · A Quick Checklist

Before drawing conclusions from case reports

When case reports are part of a sparse evidence base, check:
Identify the precise question the case report can help answer before interpreting it.
Verify the diagnosis, event, exposure, intervention, and temporal sequence as far as the report allows.
Look for alternative explanations, concurrent exposures, underlying conditions, and other plausible causes.
Check whether multiple reports may describe overlapping or duplicate cases.
Do not calculate frequency or risk from published case counts unless a valid denominator and ascertainment process are available.
Distinguish an observed temporal association from evidence establishing causation.
Consider whether selective publication of unusual cases could distort your impression of how typical the phenomenon is.
State clearly whether the evidence documents a phenomenon, generates a signal, supports a hypothesis, or contributes to another narrower conclusion.
08 · Frequently Asked Questions

Questions about using case reports as evidence

Are case reports considered research evidence?

They can provide empirical observations and may be important evidence for particular questions. Their limitations arise from what their design can establish, particularly the absence of comparison groups and often a reliable denominator.

Can case reports prove that an adverse effect exists?

They can document that an event occurred after an exposure and may generate a safety signal, especially for rare or unexpected events. Establishing that the exposure caused the event requires consideration of alternative explanations and usually additional evidence.

Can case reports be included in a systematic review?

Yes, when their inclusion fits the review question and prespecified eligibility criteria. Their role and synthesis method should match the type of information they provide rather than treating them as equivalent to comparative studies.

How many case reports are needed before the evidence becomes convincing?

There is no universal number. Additional consistent observations may strengthen a signal, but simply accumulating reports does not resolve limitations such as lack of a comparator, denominator, systematic ascertainment, or control of alternative explanations.

Are case series stronger than individual case reports?

They can provide more information about patterns across cases and may be more informative descriptively. Their ability to support causal, comparative, or frequency claims still depends on the design, sampling, denominator, ascertainment, and other methodological features.

Can a dramatic treatment response in one patient be meaningful?

It can be scientifically interesting and may generate a hypothesis, particularly when the response is unusual or mechanistically informative. One response generally cannot establish the intervention's average effect or predict how other patients will respond.

What if case reports are literally the only published evidence?

Then they may represent the best published evidence available. Use them to describe what has been observed, but preserve the uncertainty surrounding frequency, causation, effectiveness, and generalizability rather than treating the absence of stronger studies as evidence that those uncertainties have disappeared.

09 · The Bottom Line

A case report can be important without being able to answer everything

The Bottom Line

Case reports can matter greatly when stronger evidence is unavailable, particularly for documenting rare or novel phenomena and identifying signals that larger studies have not captured.

Their usefulness should not be confused with evidentiary reach. Case reports can show what was observed in particular cases, but they usually cannot establish how common an event is, whether an intervention generally works, or whether an exposure caused an outcome. Use them without asking them to become a study design they are not.

10 · Sources and Further Reading

Sources and further reading

11 · Cite this Guide

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.

Has the Field Guide helped your research?

If a guide helped clarify a question, inform a research decision, or move your work forward, I would love to hear about your experience. Your story may also help other researchers discover the Field Guide.

Share Your Experience
Takes only a few minutes